DICERNA PHARMACEUTICALS INC's ticker is DRNA and the CUSIP is 253031108. A total of 177 filers reported holding DICERNA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 3.06 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $59,712,000 | +191.9% | 1,600,000 | +100.0% | 0.39% | +49.8% |
| Q1 2021 | $20,456,000 | +16.1% | 800,000 | 0.0% | 0.26% | +37.0% |
| Q4 2020 | $17,624,000 | +22.5% | 800,000 | 0.0% | 0.19% | -10.0% |
| Q3 2020 | $14,392,000 | -29.2% | 800,000 | 0.0% | 0.21% | -36.2% |
| Q2 2020 | $20,320,000 | +2427.4% | 800,000 | +2092.0% | 0.33% | +1956.2% |
| Q4 2019 | $804,000 | +200.0% | 36,496 | -27.0% | 0.02% | -33.3% |
| Q1 2016 | $268,000 | -54.9% | 50,000 | 0.0% | 0.02% | -45.5% |
| Q4 2015 | $594,000 | -27.7% | 50,000 | -50.0% | 0.04% | +33.3% |
| Q3 2015 | $822,000 | +17.8% | 100,000 | +100.0% | 0.03% | -21.4% |
| Q2 2015 | $698,000 | – | 50,000 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 1,355,392 | $29,859,000 | 6.21% |
| Bain Capital Life Sciences Investors, LLC | 3,080,237 | $67,858,000 | 4.26% |
| DAFNA Capital Management LLC | 587,756 | $12,948,000 | 3.85% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 227,388 | $5,009,000 | 2.91% |
| RTW INVESTMENTS, LP | 7,253,857 | $159,802,000 | 2.68% |
| Parkman Healthcare Partners LLC | 331,513 | $7,303,000 | 1.87% |
| Evolutionary Tree Capital Management, LLC | 60,864 | $1,341,000 | 1.02% |
| Eagle Health Investments LP | 69,000 | $1,520,000 | 0.97% |
| Woodline Partners LP | 1,358,796 | $29,934,000 | 0.79% |
| Affinity Asset Advisors, LLC | 40,000 | $881,000 | 0.47% |